Literature DB >> 11305546

Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.

J C Redburn1, M F Murphy.   

Abstract

OBJECTIVE: To present recent trends in cervical and uterine cancer adjusted for true population at risk, using accurate estimates of the prevalence of hysterectomy where the cervix has been removed or not. To describe trends and projections of hysterectomy incidence and prevalence with and without cervix removal.
DESIGN: Collation of available NHS and private sector information.
SETTING: England and Wales. SAMPLE: NHS operations from Hospital Inpatient Enquiry, Hospital Episode Statistics and Hospital Activity Analysis for England and Wales. Private sector data from surveys with up to 97% coverage. METHODS AND MAIN OUTCOME: Measures NHS data by 5-year age group, year and operation type were collated for 1961-1995. non-NHS operations for 1981, 1986, and 1992/3 were back-projected. Hysterectomy incidence rates, 1961-95, were back-projected to estimate prevalence rates by accumulation. True populations at risk of disease and hysterectomy were calculated by applying one minus the relevant hysterectomy prevalence rates to the population by age group and year.
RESULTS: When based on the true population at risk, the age standardised cervical cancer incidence rate in 1992 was 14.4 per 100,000, compared with 12.6 when based on the all women population estimate. Incidence rates for earlier years were also affected, but there was no important effect on the rate of change over time. Absolute changes for uterine cancer are greater because the true population at risk is proportionally smaller particularly at the older ages, but there are again no major effects on the rate of change. By 1995 2.3 million women in England and Wales were without a uterus, with a peak prevalence of 21.3% in the age group 55-59. Projections based on 1995 incidence rates show hysterectomy prevalence for the screened age groups, 25-64, will now fall. Subtotal hysterectomy is 3.5% of operations and increasing.
CONCLUSIONS: True populations at risk must be used to assess the impact of screening if further reductions in cervix cancer incidence rates are not to be masked. It is essential to monitor hysterectomy by type, as subtotal hysterectomy is becoming more common. Hysterectomy incidence may have peaked. Hysterectomy prevalence in England and Wales may not be as high as would be estimated from some regional studies.

Entities:  

Mesh:

Year:  2001        PMID: 11305546     DOI: 10.1111/j.1471-0528.2001.00098.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  16 in total

1.  Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.

Authors:  Christopher H Jackson; Mark Jit; Linda D Sharples; Daniela De Angelis
Journal:  Med Decis Making       Date:  2013-07-25       Impact factor: 2.583

2.  Hormone therapy and ovarian cancer: incidence and survival.

Authors:  Karen J Wernli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2008-02-09       Impact factor: 2.506

3.  Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women's Health.

Authors:  L Wilson; N Pandeya; J Byles; G Mishra
Journal:  Epidemiol Psychiatr Sci       Date:  2017-02-13       Impact factor: 6.892

4.  Hysterectomy and perceived physical function in middle-aged Australian women: a 20-year population-based prospective cohort study.

Authors:  Louise F Wilson; Nirmala Pandeya; Julie Byles; Gita D Mishra
Journal:  Qual Life Res       Date:  2018-02-15       Impact factor: 4.147

Review 5.  Irritable bowel syndrome in midlife women: a narrative review.

Authors:  Pei-Lin Yang; Margaret M Heitkemper; Kendra J Kamp
Journal:  Womens Midlife Health       Date:  2021-05-31

6.  Adverse childhood experiences are associated with increased risk of hysterectomy and bilateral oophorectomy: A national retrospective cohort study of women in England.

Authors:  Panayotes Demakakos; Andrew Steptoe; Gita D Mishra
Journal:  BJOG       Date:  2022-02-08       Impact factor: 7.331

Review 7.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

8.  Is there an association between hysterectomy and subsequent adiposity?

Authors:  Rachel Cooper; Diana Kuh; Rebecca Hardy; Chris Power
Journal:  Maturitas       Date:  2007-10-22       Impact factor: 4.342

9.  Survival from cancer of the uterus in England and Wales up to 2001.

Authors:  N Cooper; M J Quinn; B Rachet; E Mitry; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

10.  Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.

Authors:  Shalini L Kulasingam; Steve Benard; Ruanne V Barnabas; Nathalie Largeron; Evan R Myers
Journal:  Cost Eff Resour Alloc       Date:  2008-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.